Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04234477Phase 4Withdrawn
A Phase 4 trial of metoprolol, esmolol, diltiazem, verapamil in Atrial fibrillation (AFib), sponsored by Boston University. Planned start Dec 2021; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04234477.